Product Description
SIGNIFOR is indicated for the treatment of adult patients with Cushings disease for whom pituitary surgery is not an option or has not been curative. The recommended dosage range of SIGNIFOR is 0.3 to 0.9 mg by subcutaneous injection twice a day. The recommended initial dose is either 0.6 mg or 0.9 mg twice a day.